Pfizer-19 Vaccine | The Business Standard
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
MONDAY, MAY 23, 2022
MONDAY, MAY 23, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা

Pfizer-19 Vaccine

A vial of the Pfizer vaccine against the coronavirus disease (Covid-19) is seen as medical staff are vaccinated at Sheba Medical Center in Ramat Gan, Israel December 19, 2020. REUTERS/Amir Cohen/File Photo
Coronavirus chronicle

Pfizer booster study lifts mood over Omicron variant

Vials of coronavirus disease (Covid-19) vaccines of Pfizer-BioNTech and Moderna are seen in the town of Ricany near Prague, Czech Republic, February 25, 2021. REUTERS/David W Cerny/File Photo
Coronavirus chronicle

Mixing Pfizer, AstraZ Covid-19 shots with Moderna gives better immune response: Study

Pfizer, Moderna vaccines stop infections in real-world study
Coronavirus chronicle

Pfizer, Moderna vaccines stop infections in real-world study

FILE PHOTO: Vials labelled "COVID-19 Coronavirus Vaccine" and a syringe are seen in front of the Pfizer logo in this illustration taken February 9, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
Coronavirus chronicle

Pfizer, Moderna Covid-19 vaccines highly effective after first shot in real-world use, US study shows

A healthcare worker shows a vial of Pfizer/BioNTech Covid-19 vaccine at a vaccination centre, temporarily set up in a hall of the fair, amid the coronavirus disease pandemic in Cologne, Germany, March 18, 2021. REUTERS/Thilo Schmuelgen
Coronavirus chronicle

We can get most Germans vaccinated by summer's end - BioNTech founder

Photo/Courtesy
Coronavirus chronicle

Drug executives: Big jump in US vaccine supply is coming soon

FILE PHOTO: A refrigerated truck leaves the Pfizer plant in Puurs, Belgium December 3, 2020. REUTERS/Yves Herman/File Photo
Coronavirus chronicle

Pfizer to ship 13 million Covid-19 vaccine doses per week to US by mid-March

Technicians work at Healthcare Maintenance Organisation (HMO) Maccabi's coronavirus disease (COVID-19) public laboratory, performing diverse and numerous tests, in Rehovot, Israel February 9, 2021. REUTERS/Ammar Awad
Coronavirus chronicle

Covid sickness dropped 95.8% after both Pfizer shots: Israeli Health Ministry

Pfizer promises to double supply as Biden pushes for quicker vaccine rollout
Coronavirus chronicle

Pfizer promises to double supply as Biden pushes for quicker vaccine rollout

A woman holds a small bottle labeled with a "Coronavirus Covid-19 Vaccine" sticker and a medical syringe in front of displayed Pfizer logo in this illustration taken, October 30, 2020. REUTERS/Dado Ruvic/File Photo
Coronavirus chronicle

Researchers urge delay in administering Pfizer vaccine's second dose, cite strong data

Photo: Collected.
Coronavirus chronicle

Pfizer says South African variant could significantly reduce vaccine protection

Soldiers unload medical supplies and doses of AstraZeneca coronavirus disease (COVID-19) vaccines, at the air force base in Apodaca, on the outskirts of Monterrey, Mexico February 14, 2021. REUTERS/Daniel Becerril
Coronavirus chronicle

Mexico gets AstraZeneca doses from India, expects more Pfizer

A woman reacts while receiving a vaccination against the coronavirus disease (COVID-19) as Israel continues its national vaccination drive, in East Jerusalem December 23, 2020. REUTERS/Ammar Awad//File Photo
Coronavirus chronicle

Israeli study finds 94% drop in symptomatic Covid-19 cases with Pfizer vaccine

  • Show More
The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab